Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients with Atherosclerotic Renal Artery Stenosis

BACKGROUND: Atherosclerotic renal artery stenosis (ARAS) reduces renal blood flow (RBF) and amplifies stenotic kidney (SK) hypoxia. Revascularization with percutaneous transluminal renal angioplasty and stenting (PTRA) often fails to recover renal function possibly due to ischemia reperfusion injury...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Circ Cardiovasc Interv
Main Authors: Saad, Ahmed, Herrmann, Sandra M.S., Eirin, Alfonso, Ferguson, Christopher M., Glockner, James F, Bjarnason, Haraldur, McKusick, Michael A, Misra, Sanjay, Lerman, Lilach O., Textor, Stephen C.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5659347/
https://ncbi.nlm.nih.gov/pubmed/28916603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCINTERVENTIONS.117.005487
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki